| parent | Cefotaxime | LP14831-9 |
| child | Cefotaxime [Susceptibility] | 18886-2 |
| child | Cefotaxime [Susceptibility] by Disk diffusion (KB) | 109-9 |
| child | Cefotaxime [Susceptibility] by Gradient strip | 6989-8 |
| child | Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria | 50632-9 |
| child | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | 108-1 |
| child | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | 107-3 |
| parent | Cefotaxime | LP14831-9 |
| child | Cefotaxime [Susceptibility] | 18886-2 |
| child | Cefotaxime [Susceptibility] by Disk diffusion (KB) | 109-9 |
| child | Cefotaxime [Susceptibility] by Gradient strip | 6989-8 |
| child | Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria | 50632-9 |
| child | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | 108-1 |
| child | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | 107-3 |
| PartDisplayName | en-US | Cefotaxime | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR